Abstract
The pathophysiology of non-traumatic osteonecrosis is more complex than that of traumatic osteonecrosis, and corticosteroid-induced osteonecrosis presents the greatest challenge because of the multiple effects of corticosteroids on multi-system pathways; these pathways include the effects of corticosteroids on osteoblast differentiation, osteoblast and osteoclast apoptosis, lipid metabolism, coagulation pathways, and calcium metabolism. These pathways are frequently interrelated with each other, which makes the pathogenesis even more difficult to understand. Host factors and underlying disease have been shown to play a significant role in the risk of developing osteonecrosis, and our understanding of the pathogenesis must be able to explain why some patients are at greater risk than others. Identification of genetic variants that convey additional risk will also help to personalize the way we deliver care, both in the prevention and treatment of osteonecrosis. Further understanding of the intricate immunologic and genetic pathways contributing to osteonecrosis is at the forefront of research and may soon lead to viable and less invasive non-surgical therapeutic strategies.
Similar content being viewed by others
References
Powell C, Chang C, Naguwa SM, Cheema G, Gershwin ME (2010) Steroid induced osteonecrosis: an analysis of steroid dosing risk. Autoimmun Rev 9:721–743
Chang C, Greenspan A, Gershwin ME. Osteonecrosis. In Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS (2009) Textbook of Rheumatology, 8th Edition, Saunders, Philadelphia, pp 1611–1628
Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME (2002) Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32:94–124
Spencer JD, Brookes M (1988) Avascular necrosis and the blood supply of the femoral head. Clin Orthop Relat Res 235:127–140
Jacobs B (1978) Epidemiology of traumatic and nontraumatic osteonecrosis. Clin Orthop Relat Res 130:51–67
Atsumi T, Kuroki Y (1992) Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin Orthop Relat Res 277:22–30
Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ (2003) Procoagulants and osteonecrosis. J Rheumatol 30:783–791
Jones JP Jr (1999) Coagulopathies and osteonecrosis. Acta Orthop Belg 65(Suppl 1):5–8
Chandler FA (1948) Coronary disease of the hip. J Int Coll Surg 11:34–36
Chandler FA (1949) Coronary disease of the hip. Clin Orthop Relat Res 2001:7–10
Silvestrini G, Mocetti P, Ballanti P, Di Grezia R, Bonucci E (1999) Cytochemical demonstration of the glucocorticoid receptor in skeletal cells of the rat. Endocr Res 25:117–128
Dempster DW, Moonga BS, Stein LS, Horbert WR, Antakly T (1997) Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis. J Endocrinol 154:397–406
Liesegang P, Romalo G, Sudmann M, Wolf L, Schweikert HU (1994) Human osteoblast-like cells contain specific, saturable, high-affinity glucocorticoid, androgen, estrogen, and 1 alpha, 25-dihydroxycholecalciferol receptors. J Androl 15:194–199
Yoshioka T, Sato B, Matsumoto K, Ono K (1980) Steroid receptors in osteoblasts. Clin Orthop Relat Res 148:297–303
Kerachian MA, Seguin C, Harvey EJ (2009) Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 114:121–128
Calder JD, Buttery L, Revell PA, Pearse M, Polak JM (2004) Apoptosis—a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br 86:1209–1213
Weinstein RS, Nicholas RW, Manolagas SC (2000) Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 85:2907–2912
Kogianni G, Mann V, Ebetino F, Nuttall M, Nijweide P, Simpson H, Noble B (2004) Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis. Life Sci 75:2879–2895
Weinstein RS, Chen JR, Powers CC, Stewart SA, Landes RD, Bellido T, Jilka RL et al (2002) Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109:1041–1048
Kawai K, Tamaki A, Hirohata K (1985) Steroid-induced accumulation of lipid in the osteocytes of the rabbit femoral head. A histochemical and electron microscopic study. J Bone Joint Surg Am 67:755–763
Boskey AL, Raggio CL, Bullough PG, Kinnett JG (1983) Changes in the bone tissue lipids in persons with steroid- and alcohol-induced osteonecrosis. Clin Orthop Relat Res 172:289–295
Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274–282
Wang GJ, Cui Q, Balian G (2000) The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis Clin Orthop Relat Res 370:295–310
Aspenberg P (2006) Osteonecrosis of the jaw: what do bisphosphonates do? Expert Opin Drug Saf 5:743–745
Assael LA (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg 67:35–43
Bilezikian JP (2006) Osteonecrosis of the jaw—do bisphosphonates pose a risk? N Engl J Med 355:2278–2281
Pendrys DG, Silverman SL (2008) Osteonecrosis of the jaws and bisphosphonates. Curr Osteoporos Rep 6:31–38
Walter C, Pabst A, Ziebart T, Klein M, Al-Nawas B. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro. Oral Dis 2010 (In press)
Harper RN, Moore MA, Marr MC, Watts LE, Hutchins PM (1978) Arteriolar rarefaction in the conjunctiva of human essential hypertensives. Microvasc Res 16:369–372
Kerachian MA, Harvey EJ, Cournoyer D, Chow TY, Seguin C (2006) Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13:237–244
Feng Y, Yang SH, Xiao BJ, et al (2010) Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Bone 46:32–40
Li YM, Wang SX, Gao HS, Wang JG, Wei CS, Chen LM, Hui WL et al (2004) Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence. Zhonghua Yi Xue Za Zhi 84:1348–1353
Jones JP Jr, Ramirez S, Doty SB (1993) The pathophysiologic role of fat in dysbaric osteonecrosis. Clin Orthop Relat Res 296:256–264
Gray E, Thomas S, Mistry Y, Poole S (1996) Inhibition of tissue factor and cytokine release. Haemostasis 26(Suppl 1):92–95
van Giezen JJ, Jansen JW (1992) Correlation of in vitro and in vivo decreased fibrinolytic activity caused by dexamethasone. Ann NY Acad Sci 667:199–201
Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C (2004) Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 141:47–56
Boss JH, Misselevich I (2003) Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals. Vet Pathol 40:345–354
Hirata T, Fujioka M, Takahashi KA, Asano T, Ishida M, Akioka K, Okamoto M et al (2007) Low molecular weight phenotype of Apo(a) is a risk factor of corticosteroid-induced osteonecrosis of the femoral head after renal transplant. J Rheumatol 34:516–522
Ferrari P, Schroeder V, Anderson S, Kocovic L, Vogt B, Schiesser D, Marti HP et al (2002) Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation 74:1147–1152
Kang P, Shen B, Yang J, Pei F (2008) Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head. Thromb Res 123:367–373
Chotanaphuti T, Heebthamai D, Chuwong M, Kanchanaroek K (2009) The prevalence of thrombophilia in idiopathic osteonecrosis of the hip. J Med Assoc Thai 92(Suppl 6):S141–S146
Glueck CJ, Freiberg RA, Boppana S, Wang P (2008) Thrombophilia, hypofibrinolysis, the eNOS T-786 C polymorphism, and multifocal osteonecrosis. J Bone Joint Surg Am 90:2220–2229
Glueck CJ, Freiberg RA, Wang P (2008) Heritable thrombophilia–hypofibrinolysis and osteonecrosis of the femoral head. Clin Orthop Relat Res 466:1034–1040
Seguin C, Kassis J, Busque L, Bestawros A, Theodoropoulos J, Alonso ML, Harvey EJ (2008) Non-traumatic necrosis of bone (osteonecrosis) is associated with endothelial cell activation but not thrombophilia. Rheumatology (Oxford) 47:1151–1155
Arlet J, Ficat P, Lartigue G, Tran MA (1972) Clinical research on intraosseous pressure in the upper femoral metaphysis and epiphysis in humans. Application to the diagnosis of ischemia and necrosis. Rev Rhum Mal Osteo-artic 39:717–723
Wang KZ, Mao LZ, Hu CG (1994) Experimental study on mechanism of steroid-induced avascular necrosis of femoral head. Zhonghua Wai Ke Za Zhi 32:515–517
Wang KZ, Wang CS, Wu YG, Chen H (2006) Changes of vessel in steroid-induced osteonecrosis of femoral head: experimental study of rabbits. Zhonghua Yi Xue Za Zhi 86:2024–2027
Wang ZX, Yang ZX (1985) Experimental observations on the biological features and pathogenicity of Thelazia callipaeda parasitized in rabbits. Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 3:128–130
Welch RD, Johnston CE 2nd, Waldron MJ, Poteet B (1993) Bone changes associated with intraosseous hypertension in the caprine tibia. J Bone Joint Surg Am 75:53–60
Saito S, Ohzono K, Ono K (1992) Early arteriopathy and postulated pathogenesis of osteonecrosis of the femoral head. The intracapital arterioles Clin Orthop Relat Res 277:98–110
Yang C, Yang S, Du J, Li J, Xu W, Xiong Y (2003) Experimental study of vascular endothelial growth factor gene therapy for avascular necrosis of the femoral head. J Huazhong Univ Sci Technolog Med Sci 23(297–299):316
Li X, Jin L, Cui Q, Wang GJ, Balian G (2005) Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 16:101–108
Harada I (1992) The effects of glucocorticoids on angiogenesis in vitro. Nippon Seikeigeka Gakkai Zasshi 66:763–770
Wolff JE, Guerin C, Laterra J, Bressler J, Indurti RR, Brem H, Goldstein GW (1993) Dexamethasone reduces vascular density and plasminogen activator activity in 9 L rat brain tumors. Brain Res 604:79–85
Boss JH (2004) Experimental models of osteonecrosis of the femoral head. J Orthop Sci 9:533–534
Ichiseki T, Matsumoto T, Nishino M, Kaneuji A, Katsuda S (2004) Oxidative stress and vascular permeability in steroid-induced osteonecrosis model. J Orthop Sci 9:509–515
Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T, Matsumoto T (2005) DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology (Oxford) 44:456–460
Ichiseki T, Matsumoto T (2006) Oxidative stress may underlie the sex differences seen in steroid-induced osteonecrosis models. Med Hypotheses 66:1256
Jaffe WL, Epstein M, Heyman N, Mankin HJ (1972) The effect of cortisone on femoral and humeral heads in rabbits. An experimental study. Clin Orthop Relat Res 82:221–228
Zhou Q, Li Q, Yang L, Liu F (2000) Changes of blood vessels in glucocorticoid-induced avascular necrosis of femoral head in rabbits. Zhonghua Wai Ke Za Zhi 38(212–215):213
Chen XC, Weng J, Chen XQ, Du JZ, Zhu MP, Pan YQ, Liu M (2008) Relationships among magnetic resonance imaging, histological findings, and IGF-I in steroid-induced osteonecrosis of the femoral head in rabbits. J Zhejiang Univ Sci B 9:739–746
Cui Q, Wang GJ, Su CC, Balian G (1997) The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis Clin Orthop Relat Res 344:8–19
Wang GJ, Moga DB, Richemer WG, Sweet DE, Reger SI, Thompson RC (1978) Cortisone induced bone changes and its response to lipid clearing agents. Clin Orthop Relat Res 130:81–85
Jones JP Jr (1985) Fat embolism and osteonecrosis. Orthop Clin North Am 16:595–633
Motomura G, Yamamoto T, Irisa T, Miyanishi K, Nishida K, Iwamoto Y (2008) Dose effects of corticosteroids on the development of osteonecrosis in rabbits. J Rheumatol 35:2395–2399
Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y (2004) Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 50:3387–3391
Yamamoto T, Irisa T, Sugioka Y, Sueishi K (1997) Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 40:2055–2064
Motomura G, Yamamoto T, Miyanishi K, Kondo K, Hirota Y, Iwamoto Y (2008) Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits. J Rheumatol 35:2391–2394
Tokuhara Y, Wakitani S, Oda Y, Kaneshiro Y, Masada T, Kim M, Kadoya Y et al (2009) Low levels of steroid-metabolizing hepatic enzyme (cytochrome P450 3A) activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteonecrosis even with low glucocorticoid dose. J Orthop Sci 14:794–800
Masada T, Iwakiri K, Oda Y, Kaneshiro Y, Iwaki H, Ohashi H, Takaoka K (2008) Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model. J Orthop Res 26:91–95
Kaneshiro Y, Oda Y, Iwakiri K, Masada T, Iwaki H, Hirota Y, Kondo K et al (2006) Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis. Clin Pharmacol Ther 80:396–402
Asano T, Takahashi KA, Fujioka M, Inoue S, Satomi Y, Nishino H, Tanaka T et al (2003) Genetic analysis of steroid-induced osteonecrosis of the femoral head. J Orthop Sci 8:329–333
Wang XY, Niu XH, Chen WH, Lin N, Song JN, Chen B, Jin H (2008) Effects of apolipoprotein A1 and B gene polymorphism on avascular necrosis of the femoral head in Chinese population. Zhongguo Gu Shang 21:99–102
Asano T, Takahashi KA, Fujioka M, Inoue S, Ueshima K, Hirata T, Okamoto M et al (2004) Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects. Transplantation 77:220–225
Kim TH, Hong JM, Shin ES, Kim HJ, Cho YS, Lee JY, Lee SH et al (2009) Polymorphisms in the annexin gene family and the risk of osteonecrosis of the femoral head in the Korean population. Bone 45:125–131
Kim TH, Hong JM, Oh B, Cho YS, Lee JY, Kim HL, Lee JE et al (2008) Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean population. Exp Mol Med 40:418–426
Kenzora JE (1983) Ischemic necrosis of femoral head. Part I. Accumulative cell stress: a hypothesis for the etiology of idiopathic osteonecrosis. Instr Course Lect 32:242–252
Kenzora JE (1985) Treatment of idiopathic osteonecrosis: the current philosophy and rationale. Orthop Clin North Am 16:717–725
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Powell, C., Chang, C. & Gershwin, M.E. Current Concepts on the Pathogenesis and Natural History of Steroid-Induced Osteonecrosis. Clinic Rev Allerg Immunol 41, 102–113 (2011). https://doi.org/10.1007/s12016-010-8217-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-010-8217-z